Crossmark

The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts

Published Online: 2016-03-02

Published Print: 2016-12

Authors

Mediavilla-Varela, Melanie

Boateng, Kingsley

Noyes, David

Antonia, Scott J.
Funding

Funding for this research was provided by:

National Cancer Institute (P30-CA76292)
License Information

Text and Data Mining valid from 2016-03-02

Version of Record valid from 2016-03-02
More Information

Article History

Received: 13 August 2015

Accepted: 10 February 2016

First Online: 2 March 2016

Document is current